Announcement on Wholly-owned Sub-subsidiary Obtaining Approval for Marketing of Chemical APIs

About this update from Shanghai Shyndec Pharmaceutical Co., Ltd. Class A

Announcement on Wholly-owned Sub-subsidiary Obtaining Approval for Marketing of Chemical APIs The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Shyndec Pharmaceutical Co., Ltd. Class A